US Stock MarketDetailed Quotes

GKOS Glaukos

  • 96.500
  • +1.370+1.44%
Close Apr 19 16:00 ET
  • 96.500
  • 0.0000.00%
Post 16:03 ET
4.84BMarket Cap-34712P/E (TTM)

About Glaukos Company

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Company Profile

Company NameGlaukos
Listing DateJun 25, 2015
Issue Price18.00
CEOMr. Thomas W. Burns
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Glaukos Way
CityAliso Viejo
CountryUnited States of America
Zip Code92656

Company Executives

  • Name
  • Position
  • Salary
  • Thomas W. Burns
  • Chairman of the Board and Chief Executive Officer
  • 8.65M
  • Alex R. Thurman
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 2.36M
  • Joseph E. Gilliam
  • President and Chief Operating Officer
  • 4.18M
  • Dr. Tomas Navratil
  • Chief Development Officer
  • 2.57M
  • Chris M. Calcaterra
  • Executive Vice President, Global Commercial Operations
  • 2.16M
  • Marc A. Stapley
  • Independent Director
  • 273.39K
  • David F. Hoffmeister
  • Independent Director
  • 262.13K
  • Dr. Leana S. Wen, M. Sc.,M.D.
  • Independent Director
  • 259.00K
  • Dr. Gilbert H. Kliman, M.D.
  • Independent Director
  • 259.00K
  • Denice M. Torres, J.D.,M.B.A.
  • Independent Director
  • 259.00K
  • Aimee S. Weisner
  • Independent Director
  • 259.00K
  • Mark J. Foley
  • Lead Independent Director
  • 319.38K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price